Clinical trial
The Preventive Effect and Safety of Different Doses of Insulin Nasal Administration on Postoperative Delirium in Elderly Hip Fracture Patients - a Randomized, Single Blind, Parallel Controlled, Single Center Clinical Trial
NCT06443957 is registered in ClinicalTrials.gov with The First Hospital of Jilin University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Preventive Effect and Safety of Different Doses of Insulin Nasal Administration on Postoperative Delirium in Elderly Hip Fracture Patients - a Randomized, Single Blind, Parallel Controlled, Single Center Clinical Trial
- Lead sponsor
- The First Hospital of Jilin University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 29, 2023
- Completion date
- April 13, 2024
- Enrollment
- 129 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
postoperative delirium